Trevi Therapeutics TRVI Q1 2026 Disappoints EPS 009 Below 008 Views Indian Markets Close Higher as Analyst Highlights Breakout Stock Opportunities Citius Oncol CTOR Q1 2026 Earnings Miss by Significant Key Takeaways Anthropic Takes on Pentagon in Court Over Blacklisting as Supply Chain Risk